These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 1124046

  • 1. [Nephropathy and deafness (Alport syndrome) without positive family history (author's transl)].
    Rüdiger HW, Gaertner U, Klapdor R, Neumann OG.
    Med Klin; 1975 Feb 21; 70(8):337-40. PubMed ID: 1124046
    [Abstract] [Full Text] [Related]

  • 2. [Significance of family studies and kidney biopsies in children with renal hematuria].
    Pistor K, Bachmann H, Rumpelt HJ, Olbing H.
    Monatsschr Kinderheilkd; 1985 May 21; 133(5):269-73. PubMed ID: 4010678
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome.
    Marcocci E, Uliana V, Bruttini M, Artuso R, Silengo MC, Zerial M, Bergesio F, Amoroso A, Savoldi S, Pennesi M, Giachino D, Rombolà G, Fogazzi GB, Rosatelli C, Martinhago CD, Carmellini M, Mancini R, Di Costanzo G, Longo I, Renieri A, Mari F.
    Nephrol Dial Transplant; 2009 May 21; 24(5):1464-71. PubMed ID: 19129241
    [Abstract] [Full Text] [Related]

  • 5. Absence of ocular manifestations in autosomal dominant Alport syndrome associated with haematological abnormalties.
    Colville D, Wang YY, Jamieson R, Collins F, Hood J, Savige J.
    Ophthalmic Genet; 2000 Dec 21; 21(4):217-25. PubMed ID: 11135492
    [Abstract] [Full Text] [Related]

  • 6. Autosomal dominant nephritis with renal failure of non-Alport type: clinical and molecular studies.
    Ilan T, Shohat T, Tobar A, Magal N, Yahav M, Halpern GJ, Rechavi G, Shohat M.
    Isr Med Assoc J; 2001 Jul 21; 3(7):488-91. PubMed ID: 11791413
    [Abstract] [Full Text] [Related]

  • 7. Hereditary glomerulonephritis of non-Alport type.
    Doherty CC, Middleton DT, Hill CM.
    Proc Eur Dial Transplant Assoc; 1983 Jul 21; 19():575-81. PubMed ID: 6878256
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alport's syndrome representing as crescentic glomerulonephritis: a report of two siblings.
    Harris JP, Rakowski TA, Argy WP, Schreiner GE.
    Clin Nephrol; 1978 Dec 21; 10(6):245-9. PubMed ID: 729217
    [Abstract] [Full Text] [Related]

  • 10. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].
    Endreffy E, Ondrik Z, Kemény E, Vas Z, Maróti Z, Lencse G, Bereczki C, Haszon I, Túri S, Iványi B.
    Orv Hetil; 2005 Dec 25; 146(52):2647-53. PubMed ID: 16468607
    [Abstract] [Full Text] [Related]

  • 11. [Chronic hereditary nephropathy with deafness and ocular lesions].
    Hauser J.
    Schweiz Med Wochenschr; 1974 May 18; 104(20):724-8. PubMed ID: 4829630
    [No Abstract] [Full Text] [Related]

  • 12. A novel Cys1638Tyr NC1 domain substitution in alpha5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities.
    Wilson JC, Yoon HS, Walker RJ, Eccles MR.
    Nephrol Dial Transplant; 2007 May 18; 22(5):1338-46. PubMed ID: 17277342
    [Abstract] [Full Text] [Related]

  • 13. Familial IgA nephropathy associated with bilateral sensorineural deafness.
    Chahin J, Ortiz A, Mendez L, Gallego E, Garcia-Perez J, Garcia-Castro G, Julian BA, Egido J.
    Am J Kidney Dis; 1992 Jun 18; 19(6):592-6. PubMed ID: 1595709
    [Abstract] [Full Text] [Related]

  • 14. [Alport syndrome in 23-year-old woman].
    Finke D, Bilińska W, Kałuzyński A, Nowicki M.
    Pol Merkur Lekarski; 2008 Jun 18; 24 Suppl 4():22-4. PubMed ID: 18924495
    [Abstract] [Full Text] [Related]

  • 15. A clinicopathological study of Alport syndrome and detection of type IV collagen chains in Alport patients.
    Chen N, Pan X, Ren H, Dong D.
    Chin Med J (Engl); 1998 Sep 18; 111(9):797-802. PubMed ID: 11155669
    [Abstract] [Full Text] [Related]

  • 16. [Clinical and genetic features of the Alport 'syndromes'].
    Pescucci C, Longo I, Mari F, Scala E, Bruttini M, Caselli R, Renieri A.
    G Ital Nefrol; 2005 Sep 18; 22(5):466-76. PubMed ID: 16267804
    [Abstract] [Full Text] [Related]

  • 17. Delayed diagnosis of Alport syndrome without hematuria.
    Yin-Yin C, You-Ming P, Yu-Mei L.
    Iran J Kidney Dis; 2014 May 18; 8(3):250-1. PubMed ID: 24878952
    [Abstract] [Full Text] [Related]

  • 18. Alport syndrome: clinical experience with 21 paediatric patients.
    Barten S, Proesmans W.
    Eur J Pediatr; 1996 Jan 18; 155(1):49-52. PubMed ID: 8750811
    [Abstract] [Full Text] [Related]

  • 19. [Benign familial recurring hematuria].
    Combourieu M, Attal C, Mozziconacci P.
    Ann Pediatr (Paris); 1970 Mar 02; 17(3):227-31. PubMed ID: 5440170
    [No Abstract] [Full Text] [Related]

  • 20. de-novo Alport syndrome: for the diagnosis of inherited glomerulonephritis with neither any family history nor extrarenal manifestation.
    Fukushima T, Nomura S, Kawai S, Osawa G.
    Clin Nephrol; 1997 Aug 02; 48(2):134-5. PubMed ID: 9285155
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.